Alopécie < Amantadine < Amas

Facettes :

List of bibliographic references indexed by Amantadine

Number of relevant bibliographic references: 19.

Ident.	Authors (with country if any)	Title
001351 (2011)	Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]	The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
001363 (2011)	Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada]	Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease
001C02 (2010)	Elisabeth Wolf [Autriche] ; Klaus Seppi [Autriche] ; Regina Katzenschlager [Autriche] ; Guenter Hochschorner [Autriche] ; Gerhard Ransmayr [Autriche] ; Petra Schwingenschuh [Autriche] ; Erwin Ott [Autriche] ; Iris Kloiber [Autriche] ; Dietrich Haubenberger [Autriche] ; Eduard Auff [Autriche] ; Werner Poewe [Autriche]	Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease
001F04 (2010)	Francisco De Assis Aquino Gondim [Brésil] ; Helida A. Costa [Brésil] ; Tauily C. D. Taunay [Brésil] ; Gisele R. De Oliveira [Brésil] ; Jamile Magalhaes Ferreira [Brésil] ; Francisco H. Rola [Brésil]	Transient Amantadine-Induced Musical Hallucinations in a Patient with Parkinson's Disease
002A09 (2008)	Kenichi Kashihara [Japon] ; Takaki Imamura [Japon]	Amantadine may reverse punding in Parkinson's disease—Observation in a patient
002D73 (2007)	Dariusz Koziorowski [Pologne] ; Andrzej Friedman [Pologne]	Levodopa “drug holiday” with amantadine infusions as a treatment of complications in Parkinson's disease
003466 (2006)	Alexandre Gironell [Espagne] ; Jaime Kulisevsky [Espagne] ; Berta Pascual-Sedano [Espagne] ; David Flamarich [Espagne]	Effect of amantadine in essential tremor: A randomized, placebo‐controlled trial
003584 (2006)	Rivka Inzelberg [Israël] ; Ubaldo Bonuccelli [Italie] ; Edna Schechtman [Israël] ; Ala Miniowich [Israël] ; Rosa Strugatsky [Israël] ; Roberto Ceravolo [Italie] ; Chiara Logi [Italie] ; Carlo Rossi [Italie] ; Colin Klein [Israël] ; J. Martin Rabey [Israël]	Association between amantadine and the onset of dementia in Parkinson's disease
003745 (2005)	Carlos Singer [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Manuel A. Gonzalez [États-Unis] ; Eugene L. Roberts [États-Unis] ; Abraham Lieberman [États-Unis]	Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: Report of a case series
003924 (2005)	Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal]	Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004
003E21 (2004)	Yoshiaki Furukawa [Canada] ; James J. Filiano [États-Unis] ; Stephen J. Kish [Canada]	Amantadine for levodopa‐induced choreic dyskinesia in compound heterozygotes for GCH1 mutations
004180 (2003)	Georg Ebersbach [Allemagne]	An artist's view of drug‐induced hallucinosis
004641 (2002)		Amantadine and other antiglutamate agents
004771 (2001)	Paolo Del Dotto [Italie] ; Nicola Pavese [Italie] ; Gianna Gambaccini [Italie] ; Silvia Bernardini [Italie] ; Leonard Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Ubaldo Bonuccelli [Italie]	Intravenous amantadine improves levadopa‐induced dyskinesias: An acute double‐blind placebo‐controlled study
004B29 (2000)	E. Luginger [Autriche] ; G. K. Wenning [Autriche] ; S. Bösch [Autriche] ; Werner Poewe [Autriche]	Beneficial effects of amantadine on L‐dopa‐induced dyskinesias in Parkinson's disease
004B51 (2000)	Virgilio Gerald H. Evidente [États-Unis] ; Charles H. Adler [États-Unis] ; John N. Caviness [États-Unis] ; Joseph G. Hentz [États-Unis] ; Katrina Gwinn-Hardy [États-Unis]	Amantadine is beneficial in restless legs syndrome
004C18 (1999)	Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis]	Transient benefit of amantadine in Parkinson's disease: The facts about the myth
005079 (1998)	Pierre J. Blanchet [États-Unis] ; Spyridon Konitsiotis [États-Unis] ; Thomas N. Chase [États-Unis]	Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys
005186 (1998)	T. Van Laar [Pays-Bas] ; G.-J. Lammers [Pays-Bas] ; R. A. C. Roos [Pays-Bas] ; J. J. Gerritsen [Pays-Bas] ; A. E. Meinders [Pays-Bas]	Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Amantadine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Amantadine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Amantadine
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024